Atai Beckley Ownership | Who Owns Atai Beckley?
Atai Beckley Ownership Summary
Atai Beckley is owned by 43.22% institutional investors, 2.36% insiders, and 54.42% retail investors. Ubs group is the largest institutional shareholder, holding 3.28% of ATAI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.54% of its assets in Atai Beckley shares.
ATAI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Atai Beckley | 43.22% | 2.36% | 54.42% |
| Sector | Healthcare Stocks | 35.52% | 11.86% | 52.62% |
| Industry | Biotech Stocks | 35.67% | 11.81% | 52.52% |
| Idea | Psychedelic Stocks List | 14.03% | 7.77% | 78.20% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Ubs group | 7.43M | 3.28% | $26.29M |
| Millennium management | 4.36M | 1.93% | $15.45M |
| Candriam s.c.a. | 3.09M | 1.36% | $10.93M |
| Ally bridge group (ny) | 2.29M | 1.16% | $12.10M |
| Geode capital management | 2.51M | 1.11% | $8.89M |
| Marshall wace, llp | 2.36M | 1.04% | $8.37M |
| T. rowe price investment management | 1.94M | 0.99% | $10.26M |
| Blackrock | 1.31M | 0.82% | $1.74M |
| Newtyn management | 1.78M | 0.79% | $6.31M |
| Vanguard fiduciary trust | 1.26M | 0.55% | $4.45M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Ally bridge group (ny) | 2.29M | 7.37% | $12.10M |
| Brown university | 718.50K | 2.50% | $2.54M |
| Axon capital lp | 305.80K | 1.56% | $1.08M |
| Verdad advisers, lp | 227.67K | 0.91% | $805.95K |
| Newtyn management | 1.78M | 0.67% | $6.31M |
| Adar1 capital management | 913.24K | 0.45% | $4.83M |
| Quantessence capital | 25.31K | 0.44% | $89.60K |
| Warm springs advisors | 136.40K | 0.41% | $482.86K |
| Stableford capital ii | 286.28K | 0.38% | $1.01M |
| Fore capital | 60.00K | 0.13% | $212.40K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 7.43M | 0.00% | 7.43M |
| Millennium management | 4.36M | 0.01% | 4.36M |
| Candriam s.c.a. | 3.09M | 0.06% | 3.09M |
| Geode capital management | 2.51M | 0.00% | 2.51M |
| Ally bridge group (ny) | 2.29M | 7.37% | 2.29M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Adage capital partners gp | - | - | -7.08M |
| Morgan stanley | - | - | -4.82M |
| Deep track capital, lp | - | - | -4.68M |
| Blackrock funding, inc. /de | - | - | -2.81M |
| Foresite capital management vi | - | - | -2.75M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ubs group | 7.43M | 0.00% | 7.43M | $26.29M |
| Millennium management | 4.36M | 0.01% | 4.36M | $15.45M |
| Candriam s.c.a. | 3.09M | 0.06% | 3.09M | $10.93M |
| Geode capital management | 2.51M | 0.00% | 2.51M | $8.89M |
| Ally bridge group (ny) | 2.29M | 7.37% | 2.29M | $12.10M |
Sold Out
| Holder | Change |
|---|---|
| Russell investments group | -23.00 |
| Grey fox wealth advisors | -40.00 |
| Allworth financial lp | -50.00 |
| Nelson, van denburg & campbell wealth management group | -57.00 |
| Org partners | -90.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 186 | 48.80% | 97,897,948 | 101.67% | 43 | 9.41% | 115 | 64.29% | 28 | 27.27% |
| Dec 31, 2025 | 38 | -72.46% | 4,651,628 | -89.35% | 2 | 0.43% | 19 | -77.38% | 6 | -57.14% |
| Sep 30, 2025 | 46 | -50.00% | 4,177,343 | -82.19% | 2 | 1.20% | 29 | -25.64% | 2 | -90.91% |
| Jun 30, 2025 | 97 | 14.12% | 29,160,750 | 33.18% | 16 | 10.72% | 41 | 46.43% | 23 | 9.52% |
| Mar 31, 2025 | 85 | -6.59% | 21,905,949 | 50.78% | 12 | 15.19% | 28 | -33.33% | 21 | 61.54% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Vanguard Total Stock Mkt Idx Inv | 9.31M | 2.54% | - |
| ARK Genomic Revolution ETF | 4.38M | 1.19% | 185.47K |
| ARK Genomic Revolution | 4.12M | 1.13% | 948.21K |
| Candriam Eqs L Biotech C USD Cap | 1.72M | 0.87% | 190.54K |
| iShares Biotechnology ETF | 2.15M | 0.59% | 32.36K |
| Vanguard Institutional Extnd Mkt Idx Tr | 2.16M | 0.59% | 11.30K |
| Columbia Acorn Inst | 909.73K | 0.46% | - |
| HBM Healthcare Investments AG Ord | 1.50M | 0.41% | - |
| Kieger Impact Healthcare A USD Acc | 644.10K | 0.38% | 205.80K |
| Horizons Psychedelic Stock ETF | 520.20K | 0.31% | -82.78K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Aug 14, 2025 | Apeiron Investment Group Ltd. | - | Buy | $19.00M |
| Mar 21, 2025 | Kirpekar Sahil | Chief Business Officer | Sell | $65.56K |
| Mar 21, 2025 | Craig Kevin James | Chief Medical Officer | Sell | $15.61K |
| Mar 21, 2025 | Rao Srinivas | See Remarks | Sell | $101.81K |
| Mar 21, 2025 | Johnson Anne Nagengast | Chief Financial Officer | Sell | $45.29K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q3 | 1 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | 2 | 5 |
| 2024 Q4 | - | - |
ATAI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools